PULMONARY hypertension is a common complication of diffuse obstructive pulmonary emphysema.' While obliteration of the pulmonary vascular bed may be the principal factor that causes pulmonary hypertension, it is apparent that other factors, sueh as hypoxia, increased cardiac output, and pulmonary vasomotor tone, are important contributing elements.2 In most instances in which there is resting pulmonary hypertension, an increase in cardiac output, such as is produced by exercise, is accompanied by an increase in pulmonary artery pressure and a constant or rising pulmonary vascular resistance.3 It is the purpose of the present study to determine whether the pulmonary vascular bed in emphysematous subjects can accept an increase in blood flow without an increase in pulmonary vascular pressure or resistance. Isoproterenol was used in the present study, since it has been shown to produce pulmonarv vasodilatation when perfused into the isolated and intact dog lung4' 5 and is known to have a marked inotropic and ehronotropic myocardial action in man.
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Methods Eighteen male patients with clinical and radiographic evidence of pulmonary emphysema constituted the subjects for this study. Pulmonary function tests were done in all but two subjects to substantiate further this clinical diagnosis and warrant their inclusion in the study (table 1) .
Right heart catheterization was performed with 
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determination of the resting mean pulmonary artery pressure and cardiac output by the direct Fick method in all subjects. Pulmonary wedge pressure was measured in 16 subjects. Isoproterenol in isotonic saline was then administered directly into the main pulmonary artery by constant infusion in dosages of 5 to 10 jug. per minute for a period of 6 minutes. Cardiac output and pulmonary artery pressures were then determined in all subjects during the last 2 minutes of the infusion, while wedge pressures were obtained in 16 subjects at the termination of this 6-minute period. After vascular pressures and cardiac rate had returned to control values following cessation of the infusion, graded leg exercise was performed by 13 subjects in the supine position for 6 minutes. Previous investigations in this laboratory revealed that this time interval was sufficient to establish a "steady state" in vascular pressures and cardiac output in emphysematous subjects.6
Cardiac output and pulmonary artery pressure were determined between the fourth and sixth minutes of exercise in all 13 subjects, and wedge pressures were measured in 10 subjects at the end of the sixth minute. After vascular pressures and cardiac rate had returned to control levels, a new 6-mninute exercise period was completed during which isoproterenol was infused at the same rate as during the rest control period. The Isoproterenol is capable of altering the pulmonary vascular bed of resting and exercising emphysematous subjects in such a manner that increases in pulmonary blood flowt are associated with a fall in pulmonary arterv pressure and a marked decrease in calculated pulmonary vascular resistance.
